![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2018
Anzahl der Publikationen: 3
2018
Gratzke, Christian; Maanen, Rob van; Chapple, Christopher; Abrams, Paul; Herschorn, Sender; Robinson, Dudley; Ridder, Arwin; Stoelzel, Matthias; Paireddy, Asha; Yoon, Sang Jin; Al-Shukri, Salman; Rechberger, Tomasz und Müller, Elizabeth R.
(2018):
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II).
In: European Urology, Bd. 74, Nr. 4: S. 501-509
White, William B.; Chapple, Christopher; Gratzke, Christian; Herschorn, Sender; Robinson, Dudley; Frankel, Jeffrey; Ridder, Arwin; Stoelzel, Matthias; Paireddy, Asha; Maanen, Robert van und Weber, Michael A.
(2018):
Cardiovascular Safety of the (3)-Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial.
In: Journal of Clinical Pharmacology, Bd. 58, Nr. 8: S. 1084-1091
Weber, Michael A.; Chapple, Christopher R.; Gratzke, Christian; Herschorn, Sender; Robinson, Dudley; Frankel, Jeffrey M.; Ridder, Arwin M.; Stoelzel, Matthias; Paireddy, Asha; Maanen, Robert van und White, William B.
(2018):
A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial.
In: Blood Pressure Monitoring, Bd. 23, Nr. 3: S. 153-163